Evaluating a Marker's contribution to a nomogram: The GEMCaP example

Clinical Cancer Research

Volumn 16, Issue 1, 2010, Pages 1-3

  Kattan, Michael W ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CALIBRATION; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE MARKER; GENETIC MARKER; GENOMICS; HUMAN; LABORATORY TEST; NOMOGRAM; NOTE; PATHOLOGY; PATIENT COUNSELING; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; RISK FACTOR; SURGEON; SURGICAL TECHNIQUE; SYSTEMIC THERAPY; TREATMENT DURATION; TREATMENT OUTCOME;

DISEASE PROGRESSION; HUMANS; MALE; MODELS, STATISTICAL; NOMOGRAMS; POSTOPERATIVE PERIOD; PROSTATIC NEOPLASMS; RECURRENCE; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL;

EID: 74949103552     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-2946     Document Type: Note

References (8)

1. Paris P, Weinberg V, Albo G. A group of genome based biomarkers that add to the Kattan nomogram for predicting progression in men with high-risk prostate cancer. Clin Cancer Res 2010;16:195-202.
2. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999;17:1499-507.
3. Graefen M, Karakiewicz P, Cagiannos I, et al. A validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol 2002;20:951-6.
4. Stephenson A, Scardino P, Eastham J, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2005;23:7005-12.
5. Kattan M, Vickers A, Yu C, et al. Preoperative and postoperative nomograms incorporating surgeon experience for localized prostate cancer. Cancer 2009;115:1005-10.
6. Cook N. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007;115:928-35.
7. Kattan MW. Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst 2003;95:634-5.
8. Simon R. Development and evaluation of therapeutically relevant predictive classifiers using gene expression profiling. J Natl Cancer Inst 2006;98:1169-71.